UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$21.6B |
| 2 |
Amazon
AMZN
|
+$13.7B |
| 3 |
NVIDIA
NVDA
|
+$3.87B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.89B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$22.7B |
| 2 |
Equinix
EQIX
|
+$857M |
| 3 |
Digital Realty Trust
DLR
|
+$655M |
| 4 |
NetEase
NTES
|
+$618M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$609M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.9% |
| 2 | Financials | 13.9% |
| 3 | Consumer Discretionary | 11.31% |
| 4 | Healthcare | 10.7% |
| 5 | Communication Services | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Lionsgate Studios
LION
$3.86B
| $823K | ﹤0.01% |
+141,738
| New | +$948K |
|
2427
TORM
TRMD
$3.02B
| $823K | ﹤0.01% |
49,391
-44,528
| -47% | -$744K |
|
2428
Bristow Group
VTOL
$1.36B
| $823K | ﹤0.01% |
24,952
+6,519
| +35% | +$197K |
|
2429
Opendoor
OPEN
$3.38B
| $818K | ﹤0.01% |
1,586,201
+538,350
| +51% | +$389K |
|
2430
Usana Health Sciences
USNA
$286M
| $817K | ﹤0.01% |
26,762
+9,462
| +55% | +$269K |
|
2431
Cullinan Oncology
CGEM
$1.14B
| $803K | ﹤0.01% |
106,580
+26,227
| +33% | +$211K |
|
|
FBRT
2432
Franklin BSP Realty Trust
FBRT
$657M
| $802K | ﹤0.01% |
75,030
-78,444
| -51% | -$881K |
|
2433
MakeMyTrip
MMYT
$5.64B
| $794K | ﹤0.01% |
8,101
+684
| +9% | +$69K |
|
2434
Arm
ARM
$302B
| $791K | ﹤0.01% |
4,890
| – | – |
|
2435
Vista Energy
VIST
$7.32B
| $789K | ﹤0.01% |
+16,500
| New | +$781K |
|
2436
Enel Chile
ENIC
$6.28B
| $779K | ﹤0.01% |
214,632
| – | – |
|
|
NXRT
2437
NexPoint Residential Trust
NXRT
$652M
| $772K | ﹤0.01% |
23,170
-108,864
| -82% | -$3.85M |
|
|
EFXT
2438
Enerflex
EFXT
$2.44B
| $771K | ﹤0.01% |
97,716
-5,416
| -5% | -$38.7K |
|
2439
Preformed Line Products
PLPC
$2.28B
| $760K | ﹤0.01% |
+4,753
| New | +$677K |
|
|
NXDR
2440
Nextdoor Holdings
NXDR
$986M
| $751K | ﹤0.01% |
452,341
-2,603
| -0.6% | -$3.93K |
|
|
LENZ
2441
LENZ Therapeutics
LENZ
$168M
| $737K | ﹤0.01% |
+25,155
| New | +$684K |
|
2442
Pulse Biosciences
PLSE
$3.02B
| $729K | ﹤0.01% |
48,331
+11,800
| +32% | +$196K |
|
2443
iShares MSCI Philippines ETF
EPHE
$145M
| $724K | ﹤0.01% |
26,700
| – | – |
|
2444
Dr. Reddy's Laboratories
RDY
$10.2B
| $722K | ﹤0.01% |
48,022
-3,470
| -7% | -$49.6K |
|
2445
Boston Omaha
BOC
$436M
| $717K | ﹤0.01% |
51,098
+26,111
| +104% | +$380K |
|
|
ADAM
2446
Adamas Trust
ADAM
$883M
| $716K | ﹤0.01% |
106,836
-135,648
| -56% | -$861K |
|
|
NOAH
2447
Noah Holdings
NOAH
$603M
| $709K | ﹤0.01% |
+59,370
| New | +$599K |
|
2448
Crawford & Co Class A
CRD.A
$669M
| $706K | ﹤0.01% |
66,721
+11,348
| +20% | +$121K |
|
2449
Rocket Pharmaceuticals
RCKT
$394M
| $701K | ﹤0.01% |
286,312
+101,620
| +55% | +$515K |
|
|
AAUC
2450
Allied Gold Corp
AAUC
$2.76B
| $700K | ﹤0.01% |
+51,812
| New | +$733K |
|
Similar funds
UBS AM's Q2 2025 Portfolio in Review
As of Q2 2025, UBS AM held 2,749 positions worth $494B, up 26% from $391B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
UBS AM deployed $54.3B of net new capital in Q2 2025, opening 106 new positions and adding to 2,036 existing holdings. Its largest new stake was Amrize Ltd: 12,343,881 shares worth $612M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Microsoft, an estimated $22.7B trimmed.
- UBS AM's largest Q2 2025 buy was Amrize Ltd: 12,343,881 shares worth $612M.
- UBS AM added most to Apple in Q2 2025, an estimated $21.6B increase.
- UBS AM's biggest Q2 2025 reduction was Microsoft, cutting an estimated $22.7B.
- UBS AM fully exited Discover Financial Services in Q2 2025, selling an estimated $356M.
- UBS AM's ten largest holdings make up 28% of its $494B portfolio in Q2 2025.
- UBS AM opened 106 new positions and closed 128 in Q2 2025.
- UBS AM's portfolio value rose 26% quarter-over-quarter to $494B.
Based on UBS AM's 13F filing for Q2 2025, filed 14 Aug 2025.